VYNE Therapeutics Inc. (VYNE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for VYNE Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.94x | -3.58x | -0.84x | -0.37x | -0.72x | -0.80x |
| P/B Ratio | 0.89x | 2.74x | 0.27x | 0.28x | 1.08x | 5.46x |
| P/S Ratio | 43.53x | 284.78x | 56.45x | 18.03x | 56.38x | 9.76x |
| Profitability | ||||||
| Gross Margin | 96.0% | 100.0% | 100.0% | 100.0% | 100.0% | 93.4% |
| Operating Margin | -5219.1% | -8710.0% | -6900.5% | -7189.7% | -4179.5% | 1203.0% |
| Net Margin | -4646.1% | -7950.9% | -6710.4% | -4865.8% | -7876.4% | -1217.4% |
| EBITDA Margin | -4689.8% | -8709.2% | -6900.5% | -7174.6% | -4167.8% | -1196.1% |
| Liquidity | ||||||
| Current Ratio | 12.53x | 4.35x | 12.73x | 4.10x | 3.43x | 4.01x |
| Quick Ratio | 12.53x | 4.35x | 12.73x | 4.10x | 3.04x | 3.67x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.93x |
YoY = year-over-year change. Source: FMP..